PROM1 and neoplasm: When the cases were stratified according to tumor location and MMR status (Table 3), CD133 immunopositivity was identified in 28 of the 40 (70.0%) right-sided and 36 of the 40 (90.0%) left-sided CRC (p = 0.025).